191 – 200 of 212
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Association of cerebrospinal fluid neurofilament light concentration with Alzheimer disease progression
(
- Contribution to journal › Article
-
Mark
Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia
(
- Contribution to journal › Article
-
Mark
No diurnal variation of classical and candidate biomarkers of Alzheimer's disease in CSF
(
- Contribution to journal › Article
- 2015
-
Mark
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
(
- Contribution to journal › Article
-
Mark
First Administration of the Fc-Attenuated Anti-β Amyloid Antibody GSK933776 to Patients with Mild Alzheimer's Disease: A Randomized, Placebo-Controlled Study.
(
- Contribution to journal › Article
-
Mark
CSF biomarkers and clinical progression of Parkinson disease.
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Amyloid biomarkers in Alzheimer's disease.
(
- Contribution to journal › Scientific review
-
Mark
Increased CSF biomarkers of angiogenesis in Parkinson disease.
(
- Contribution to journal › Article